Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  11,835 results for ""Formoterol Fumarate""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Beclometasone Dipropionate/Formoterol Fumarate is Similarly Effective to Budesonide/Formoterol Fumarate in Chinese Patients with COPD: The FORSYYN Double-Blind, Randomised Study.

  • Authors : Wen F; Department of Respiratory and Critical Care Medicine, West China Hospital, Chengdu, China.; Wu Y

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/therapeutic use ; Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/therapeutic use

  • Source: COPD [COPD] 2024 Dec; Vol. 21 (1), pp. 2425157. Date of Electronic Publication: 2024 Nov 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101211769 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial.

  • Authors : Watz H; Velocity Clinical Research Grosshansdorf, Airway Research Center North (ARCN), Formerly Pulmonary Research Institute at Lung Clinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Wöhrendamm 80, 22927, Grosshansdorf, Germany. .; Kirsten AM

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis

  • Source: Respiratory research [Respir Res] 2024 Oct 17; Vol. 25 (1), pp. 378. Date of Electronic Publication: 2024 Oct 17.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.

  • Authors : Rony F; Global Clinical Development, Chiesi SAS, Bois Colombes, France. Electronic address: .; Cortellini M

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/pharmacokinetics ; Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacokinetics

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2024 Jun; Vol. 85, pp. 102299. Date of Electronic Publication: 2024 Apr 23.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The carbon footprint of as-needed budesonide/formoterol in mild asthma: a post hoc analysis.

  • Authors : Hatter L; Medical Research Institute of New Zealand, Wellington, New Zealand .; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Carbon Footprint*

  • Source: The European respiratory journal [Eur Respir J] 2024 Jul 11; Vol. 64 (1). Date of Electronic Publication: 2024 Jul 11 (Print Publication: 2024).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Small Airways Disease Affects Aerosol Deposition in Children with Severe Asthma: A Functional Respiratory Imaging Study.

  • Authors : van den Bosch WB; Department of Pediatrics, Division of Respiratory Medicine and Allergy, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Asthma*/Asthma*/Asthma*/physiopathology ; Aerosols*

  • Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2024 Dec; Vol. 37 (6), pp. 351-361. Date of Electronic Publication: 2024 Sep 04.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Influence of β 2 -adrenergic selective agonist formoterol on the motor unit of a mouse model of a congenital myasthenic syndrome with complete VAChT deletion.

  • Authors : Rossi L; Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Mota BI

Subjects: Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/drug therapy ; Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/genetics ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacology

  • Source: Neuropharmacology [Neuropharmacology] 2024 Dec 01; Vol. 260, pp. 110116. Date of Electronic Publication: 2024 Aug 14.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Formulation and evaluation of carrier-based dry powders containing budesonide and arformoterol for inhalation therapy.

  • Authors : Oh DW; Korea United Pharm R&D Center, Gangnam-gu, Republic of Korea.; Choi JH

Subjects: Dry Powder Inhalers*/Dry Powder Inhalers*/Dry Powder Inhalers*/methods ; Asthma*/Asthma*/Asthma*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage

  • Source: Pharmaceutical development and technology [Pharm Dev Technol] 2024 Nov; Vol. 29 (9), pp. 966-975. Date of Electronic Publication: 2024 Oct 23.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9610932 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Real-life utilization of fixed triple therapy in COPD: The Trilife study. Beclomethasone/formoterol/glycopyrronium triple fixed-dose therapy in extra-fine particles].

  • Authors : Roche N; Pneumologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France. Electronic address: .; Bernady A

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/administration & dosage

  • Source: Revue des maladies respiratoires [Rev Mal Respir] 2024 Dec; Vol. 41 (10), pp. 715-726. Date of Electronic Publication: 2024 Nov 01.Publisher: Elsevier-Masson Country of Publication: France NLM ID: 8408032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The β 2 -adrenergic receptor agonist formoterol attenuates necrosis and apoptosis in the rat myocardium under experimental stress-induced cardiac injury.

  • Authors : Naryzhnaya NV; Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia, 111a, Kievskaya str., Tomsk, 634012, Russian Federation.; Logvinov SV

Subjects: Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacology ; Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/pharmacology

  • Source: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2024 Dec; Vol. 38 (6), pp. 1116-1130. Date of Electronic Publication: 2024 Jul 02.Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Formoterol dynamically alters endocannabinoid tone in the periaqueductal gray inducing headache.

  • Authors : Peterson IL; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, United States.; Liktor-Busa E

Subjects: Endocannabinoids*/Endocannabinoids*/Endocannabinoids*/metabolism ; Periaqueductal Gray*/Periaqueductal Gray*/Periaqueductal Gray*/metabolism ; Periaqueductal Gray*/Periaqueductal Gray*/Periaqueductal Gray*/drug effects

  • Source: The journal of headache and pain [J Headache Pain] 2024 Nov 19; Vol. 25 (1), pp. 200. Date of Electronic Publication: 2024 Nov 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100940562 Publication Model: Electronic Cited Medium: Internet ISSN: 1129-2377

Record details

Read More Add to Saved list
×
  • 1-10 of  11,835 results for ""Formoterol Fumarate""